Abstract

The Combo stent is a drug eluting stent with abluminal sirolimus in a bioabsorbable polymer and luminal anti-CD34 for endothelial progenitor capture and rapid endothelialization. This property may permit shorter period of dual antiplatelet therapy (DAPT) in patients at high bleeding risk (HBR). We

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call